Description: Generic Drug Product Development : Bioequivalence Issues, Hardcover by Kanfer, Isadore; Shargel, Leon, ISBN 0849377846, ISBN-13 9780849377846, Like New Used, Free shipping in the US The assessment of bioequivalence is an important process whereby the bioavailability of a generic drug product is compared with its brand-name counterpart. Generic pharmaceutical products must be approved as therapeutic equivalents to the brand name alternative in order to be interchangeable. The demonstration of bioequivalence is an important component of therapeutic equivalence. Bioequivalence studies are very expensive, time consuming and always have the possibility of failure. The objective of this textbook is to describe some of those specific bioequivalence issues which need to be considered for the design and conduct of bioequivalence studies. By exploring scientific, legal, and international regulatory challenges, Generic Drug Development, discusses the use of alternative approaches to the measurement of plasma drug concentrations for the demonstration of bioequivalence, and covers bioequivalence procedures for drug products that are not easily assessed - based upon the physical and chemical properties of the active drug and the nature of the drug product.
Price: 193.31 USD
Location: Jessup, Maryland
End Time: 2025-01-01T09:46:21.000Z
Shipping Cost: 0 USD
Product Images
Item Specifics
Return shipping will be paid by: Buyer
All returns accepted: Returns Accepted
Item must be returned within: 14 Days
Refund will be given as: Money Back
Return policy details:
Book Title: Generic Drug Product Development : Bioequivalence Issues
Number of Pages: 288 Pages
Language: English
Publication Name: Generic Drug Product Development : Bioequivalence Issues
Publisher: CRC Press LLC
Subject: Pharmacy, Pharmacology
Item Height: 0.8 in
Publication Year: 2007
Item Weight: 17.6 Oz
Type: Textbook
Subject Area: Medical
Item Length: 9.1 in
Author: Isadore Kanfer, Leon Shargel
Item Width: 6.4 in
Format: Hardcover
